The next catalyst should be the launch of the OTC version of Microcyn skin & wound HydroGel in October 2009.
If Oculus can break into China's market as mentioned by the CEO ("Look at the population of China, for example. That's a population ten times the size of Mexico. We have an approval. We have a partnership with the largest drug company in China."), then it's off to the race tracks for Oculus, IMHO.